What is HC Wainwright’s Forecast for MLTX Q1 Earnings?
MoonLake Immunotherapeutics (NASDAQ:MLTX – Free Report) – Equities research analysts at HC Wainwright dropped their Q1 2025 earnings estimates for MoonLake Immunotherapeutics in a report issued on Thursday, February 27th. HC Wainwright analyst R. Selvaraju now anticipates that the company will earn ($0.77) per share for the quarter, down from their prior estimate of ($0.69). […]
MoonLake Immunotherapeutics (NASDAQ:MLTX – Free Report) – Equities research analysts at HC Wainwright dropped their Q1 2025 earnings estimates for MoonLake Immunotherapeutics in a report issued on Thursday, February 27th. HC Wainwright analyst R. Selvaraju now anticipates that the company will earn ($0.77) per share for the quarter, down from their prior estimate of ($0.69). […]
